Literature DB >> 34408018

14-3-3ζ: A suppressor of inflammatory arthritis.

Joshua Kim1, Krista Chun1, Jenna McGowan1, Youjie Zhang1, Piotr J Czernik1, Blair Mell1, Bina Joe1, Saurabh Chattopadhyay2, Joseph Holoshitz3, Ritu Chakravarti4.   

Abstract

Inflammatory arthritis (IA) is a common disease that affects millions of individuals worldwide. Proinflammatory events during IA pathogenesis are well studied; however, loss of protective immunity remains underexplored. Earlier, we reported that 14-3-3zeta (ζ) has a role in T-cell polarization and interleukin (IL)-17A signal transduction. Here, we demonstrate that 14-3-3ζ knockout (KO) rats develop early-onset severe arthritis in two independent models of IA, pristane-induced arthritis and collagen-induced arthritis. Arthritic 14-3-3ζ KO animals showed an increase in bone loss and immune cell infiltration in synovial joints. Induction of arthritis coincided with the loss of anti-14-3-3ζ antibodies; however, rescue experiments to supplement the 14-3-3ζ antibody by passive immunization did not suppress arthritis. Instead, 14-3-3ζ immunization during the presymptomatic phase resulted in significant suppression of arthritis in both wild-type and 14-3-3ζ KO animals. Mechanistically, 14-3-3ζ KO rats exhibited elevated inflammatory gene signatures at the messenger RNA and protein levels, particularly for IL-1β. Furthermore, the immunization with recombinant 14-3-3ζ protein suppressed IL-1β levels, significantly increased anti-14-3-3ζ antibody levels and collagen production, and preserved bone quality. The 14-3-3ζ protein increased collagen expression in primary rat mesenchymal cells. Together, our findings indicate that 14-3-3ζ causes immune suppression and extracellular remodeling, which lead to a previously unrecognized IA-suppressive function.

Entities:  

Keywords:  14-3-3zeta; Il-1beta; bone loss; collagen; inflammatory arthritis

Mesh:

Substances:

Year:  2021        PMID: 34408018      PMCID: PMC8403930          DOI: 10.1073/pnas.2025257118

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  73 in total

1.  Regulation of dendritic cells and macrophages by an anti-apoptotic cell natural antibody that suppresses TLR responses and inhibits inflammatory arthritis.

Authors:  Yifang Chen; Sahil Khanna; Carl S Goodyear; Yong Beom Park; Eyal Raz; Steffen Thiel; Caroline Grönwall; Jaya Vas; David L Boyle; Maripat Corr; Dwight H Kono; Gregg J Silverman
Journal:  J Immunol       Date:  2009-06-29       Impact factor: 5.422

Review 2.  Moonlighting chaperone-like activity of the universal regulatory 14-3-3 proteins.

Authors:  Nikolai N Sluchanko; Nikolai B Gusev
Journal:  FEBS J       Date:  2017-01-06       Impact factor: 5.542

3.  Characteristics of autoantibodies targeting 14-3-3 proteins and their association with clinical features in newly diagnosed giant cell arteritis.

Authors:  Anne Kistner; Marc B Bigler; Kathrin Glatz; Simon B Egli; Fabian S Baldin; Florian A Marquardsen; Matthias Mehling; Katharina M Rentsch; Daniel Staub; Markus Aschwanden; Mike Recher; Thomas Daikeler; Christoph T Berger
Journal:  Rheumatology (Oxford)       Date:  2017-05-01       Impact factor: 7.580

4.  Relationships of common polymorphisms in IL-6, IL-1A, and IL-1B genes with susceptibility to osteoarthritis: a meta-analysis.

Authors:  Hao Cai; Huan-Jian Sun; You-Hua Wang; Zhe Zhang
Journal:  Clin Rheumatol       Date:  2014-06-21       Impact factor: 2.980

Review 5.  Autoantigens and immune pathways in rheumatoid arthritis.

Authors:  Valerie M Corrigall; Gabriel S Panayi
Journal:  Crit Rev Immunol       Date:  2002       Impact factor: 2.214

Review 6.  14-3-3 modulation of the inflammatory response.

Authors:  Claire C Munier; Christian Ottmann; Matthew W D Perry
Journal:  Pharmacol Res       Date:  2020-10-11       Impact factor: 7.658

Review 7.  Animal models of rheumatoid arthritis and related inflammation.

Authors:  B Joe; M M Griffiths; E F Remmers; R L Wilder
Journal:  Curr Rheumatol Rep       Date:  1999-12       Impact factor: 4.592

8.  Characterization of pristane-induced arthritis, a murine model of chronic disease: response to antirheumatic agents, expression of joint cytokines, and immunopathology.

Authors:  Christopher Patten; Katherine Bush; Inma Rioja; Rebecca Morgan; Paul Wooley; John Trill; Paul Life
Journal:  Arthritis Rheum       Date:  2004-10

9.  14-3-3ζ-TRAF5 axis governs interleukin-17A signaling.

Authors:  Jenna McGowan; Cara Peter; Joshua Kim; Sonam Popli; Brent Veerman; Jessica Saul-McBeth; Heather Conti; Shondra M Pruett-Miller; Saurabh Chattopadhyay; Ritu Chakravarti
Journal:  Proc Natl Acad Sci U S A       Date:  2020-09-23       Impact factor: 11.205

10.  Protective Efficacy and Mechanism of Passive Immunization with Polyclonal Antibodies in a Sepsis Model of Staphylococcus aureus Infection.

Authors:  Jinyong Zhang; Feng Yang; Xiaoli Zhang; Haiming Jing; Chunyan Ren; Changzhi Cai; Yandong Dong; Yudong Zhang; Quanming Zou; Hao Zeng
Journal:  Sci Rep       Date:  2015-10-22       Impact factor: 4.379

View more
  2 in total

Review 1.  A broad look into the future of rheumatoid arthritis.

Authors:  Johanna Mucke; Martin Krusche; Gerd R Burmester
Journal:  Ther Adv Musculoskelet Dis       Date:  2022-02-09       Impact factor: 5.346

Review 2.  Reestablish immune tolerance in rheumatoid arthritis.

Authors:  Ziqiang Shuai; Shuang Zheng; Kang Wang; Jian Wang; Patrick S C Leung; Bin Xu
Journal:  Front Immunol       Date:  2022-09-30       Impact factor: 8.786

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.